drugset / Trial / NCT02147249
Cytokines and Chemokines in Erythema Migrans
Unknown
150 enrolled
University Medical Centre Ljubljana
Harvard University · collabMedical University of Vienna · collabUniversity of Ljubljana School of Medicine, Slovenia · collab
NaSingle-groupOpen-labelBasic science
Summary
The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with erythema migrans to gain better insight into pathogenesis of early Lyme borreliosis and to define new immune modulators that could serve as biomarkers of disease activity.
Timeline
- Start
- 2013-07
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 500 mg | Oral |
| Subject | Doxycycline | Small molecule | 100 mg | Oral |
| Subject | cefuroxime axetil | Small molecule | 500 mg | Oral |
Indications
No indication recorded.